Steven C. Wallis

7.3k total citations
184 papers, 4.6k citations indexed

About

Steven C. Wallis is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Steven C. Wallis has authored 184 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Pharmacology, 62 papers in Molecular Medicine and 60 papers in Epidemiology. Recurrent topics in Steven C. Wallis's work include Antibiotics Pharmacokinetics and Efficacy (152 papers), Antibiotic Resistance in Bacteria (62 papers) and Pneumonia and Respiratory Infections (34 papers). Steven C. Wallis is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (152 papers), Antibiotic Resistance in Bacteria (62 papers) and Pneumonia and Respiratory Infections (34 papers). Steven C. Wallis collaborates with scholars based in Australia, France and United Kingdom. Steven C. Wallis's co-authors include Jeffrey Lipman, Jason A. Roberts, Suzanne L. Parker, Jan J. De Waele, Andrew Udy, Jordi Rello, Lawrence R. Gahan, John F. Fraser, Claire M. Rickard and Kiran Shekar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Steven C. Wallis

170 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven C. Wallis Australia	37	3.3k	1.7k	1.3k	842	593	184	4.6k
Mohd H. Abdul‐Aziz Australia	21	2.5k 0.7×	1.4k 0.9×	1.0k 0.8×	815 1.0×	458 0.8×	70	3.1k
Markus Zeitlinger Austria	41	2.5k 0.8×	1.5k 0.9×	1.2k 0.9×	531 0.6×	1.3k 2.1×	340	6.9k
Andrew Udy Australia	38	3.2k 1.0×	2.6k 1.6×	903 0.7×	849 1.0×	905 1.5×	215	6.5k
Federico Pea Italy	44	4.5k 1.4×	2.5k 1.5×	1.9k 1.5×	1.2k 1.4×	2.3k 3.9×	278	7.5k
Jacobus Ungerer Australia	37	1.6k 0.5×	1.1k 0.7×	508 0.4×	461 0.5×	346 0.6×	168	4.6k
Brett McWhinney Australia	37	1.7k 0.5×	1.0k 0.6×	522 0.4×	468 0.6×	314 0.5×	143	4.5k
Christian Joukhadar Austria	40	1.9k 0.6×	1.3k 0.8×	865 0.7×	223 0.3×	1.0k 1.8×	100	4.4k
Manjunath P. Pai United States	37	2.7k 0.8×	1.9k 1.2×	681 0.5×	653 0.8×	3.1k 5.3×	176	6.6k
José Artur Paiva Portugal	29	1.1k 0.3×	2.4k 1.4×	700 0.5×	798 0.9×	1.4k 2.3×	149	4.9k
David E. Nix United States	39	2.7k 0.8×	2.7k 1.7×	1.4k 1.1×	483 0.6×	1.4k 2.3×	140	5.8k

Countries citing papers authored by Steven C. Wallis

Since Specialization

Citations

This map shows the geographic impact of Steven C. Wallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. Wallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. Wallis more than expected).

Fields of papers citing papers by Steven C. Wallis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. Wallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. Wallis. The network helps show where Steven C. Wallis may publish in the future.

Co-authorship network of co-authors of Steven C. Wallis

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. Wallis. A scholar is included among the top collaborators of Steven C. Wallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. Wallis. Steven C. Wallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sulaiman, Helmi, Mohd Shahnaz Hasan, Janattul‐Ain Jamal, et al.. (2025). Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment. Scientific Reports. 15(1). 37781–37781.

Heffernan, Aaron J., Xin Liu, Suzanne L. Parker, et al.. (2025). Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patients. International Journal of Antimicrobial Agents. 65(5). 107461–107461.

Gurunathan, Usha, Robert L. Medcalf, Zikou Liu, et al.. (2025). A pharmacokinetic/pharmacodynamic analysis of intravenous tranexamic acid in adult patients undergoing elective total hip arthroplasty (ORACLE). British Journal of Anaesthesia. 136(4). 1157–1165.

Sime, Fekade B., Sainath Raman, Menino Osbert Cotta, et al.. (2025). The FUSION Study: compatibility of antibiotics with commonly used medication infusions in a paediatric intensive care unit. European Journal of Hospital Pharmacy. 33(2). 126–136.

Roberts, Jason A., et al.. (2024). Propofol does not alter the protein binding and unbound concentration of lidocaine at clinically targeted plasma concentrations in vitro – A short communication. Anaesthesia Critical Care & Pain Medicine. 43(5). 101419–101419. 3 indexed citations

Parker, Suzanne L., Fabian Chiong, Cherian Sajiv, et al.. (2024). Population pharmacokinetics of unbound cefazolin in infected hospitalized patients requiring intermittent high-flux haemodialysis: can a three-times-weekly post-dialysis dosing regimen provide optimal treatment?. Journal of Antimicrobial Chemotherapy. 79(11). 2980–2989. 3 indexed citations

Parker, Suzanne L., Cristina Sanches, Mariana Millan Fachi, et al.. (2023). Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic Analysis. Tropical Medicine and Infectious Disease. 8(6). 312–312.

Wallis, Steven C., Elizabeth E. Morgan, Michael N. Dudley, et al.. (2023). A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects. Antimicrobial Agents and Chemotherapy. 68(1). e0109923–e0109923. 1 indexed citations

Sumi, Chandra Datta, Aaron J. Heffernan, Kyra Cottrell, et al.. (2022). Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates. Journal of Antimicrobial Chemotherapy. 77(11). 3026–3034. 3 indexed citations

10.

Lim, Sazlyna Mohd Sazlly, et al.. (2022). Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Isolates in a Hollow-Fibre Infection Model. Antibiotics. 11(11). 1578–1578. 8 indexed citations

11.

Abdul‐Aziz, Mohd H., Fay Burrows, Hergen Buscher, et al.. (2021). Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study). International Journal of Antimicrobial Agents. 58(6). 106466–106466. 19 indexed citations

12.

Heffernan, Aaron J., Fekade B. Sime, Derek S. Sarovich, et al.. (2020). Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 64(9). 8 indexed citations

13.

Bergen, Phillip J., Steven C. Wallis, Anton Y. Peleg, et al.. (2020). Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model. Antimicrobial Agents and Chemotherapy. 64(7). 11 indexed citations

14.

Valero, Yarmarly C. Guerra, Gordon Choi, Steven C. Wallis, et al.. (2019). In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration. International Journal of Antimicrobial Agents. 54(2). 261–264. 9 indexed citations

15.

Sime, Fekade B., Melissa Lassig‐Smith, Therese Starr, et al.. (2019). Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction. Antimicrobial Agents and Chemotherapy. 63(10). 44 indexed citations

16.

Sime, Fekade B., Saurabh Pandey, Suzanne L. Parker, et al.. (2018). Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam. Antimicrobial Agents and Chemotherapy. 62(10). 27 indexed citations

17.

Sime, Fekade B., Janine Stuart, Therese Starr, et al.. (2018). A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration. International Journal of Antimicrobial Agents. 52(4). 506–509. 7 indexed citations

18.

Roger, Claire, Menino Osbert Cotta, Laurent Müller, et al.. (2017). Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients. International Journal of Antimicrobial Agents. 50(2). 227–231. 20 indexed citations

19.

Smith, Nicholas, et al.. (2012). Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime. Critical Care and Resuscitation. 14(4). 312–315. 36 indexed citations

20.

Shekar, Kiran, Jason A. Roberts, Susan Welch, et al.. (2012). ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. SHILAP Revista de lepidopterología. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact